Multiple factors contribute to adherence, including discontinuation due to side effects, ineffectiveness, drug shortages, employer coverage and out-of-pocket costs
in replete individuals extra B12 is largely excreted and does not enhance energy or performance [2]
Although currently no significant differences in reducing AHI have been identified between GLP-1 RAs alone or in combination with CPAP versus CPAP alone, patients with obesity and OSA may consider GLP-1 RA as a potential treatment option if the adverse events are deemed tolerable
Weight loss medications, such as Wegovy (Semaglutide) and Zepbound (Tirzepatide), work by increasing levels of GLP-1, a naturally occurring hormone that regulates hunger and glucose
Si se usa semaglutida con insulina o una sustancia que causa la secrecin de insulina, los pacientes deben hablar con su proveedor sobre la posibilidad de reducir la dosis de insulina o el frmaco inductor de insulina para reducir el riesgo de hipoglucemia
The starting dose is 0.25 milligrams for 4 weeks before increasing the dosage to 0.5 milligrams
